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Abstract. A time-domain multiwavelength (635 to 1060 nm)
optical mammography was performed on 147 subjects with
recent x-ray mammograms available, and average breast
tissue composition (water, lipid, collagen, oxy- and deoxy-
hemoglobin) and scattering parameters (amplitude a and
slope b) were estimated. Correlation was observed between
optically derived parameters and mammographic density
[Breast Imaging and Reporting Data System (BI-RADS) cat-
egories], which is a strong risk factor for breast cancer.
A regression logistic model was obtained to best identify
high-risk (BI-RADS 4) subjects, based on collagen content
and scattering parameters. The model presents a total mis-
classification error of 12.3%, sensitivity of 69%, specificity
of 94%, and simple kappa of 0.84, which compares favor-
ably even with intraradiologist assignments of BI-RADS
categories. © The Authors. Published by SPIE under a Creative Commons
Attribution 3.0 Unported License. Distribution or reproduction of this work in
whole or in part requires full attribution of the original publication, including
its DOI. [DOI: 10.1117/1.JBO.18.6.060507]
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Breast cancer is a leading cause of death in women and a major
health burden worldwide: one in eight women in the United
States will be diagnosed with breast cancer in their lifetime.1
Early diagnosis (tumor size <1 cm, no lymph node involvement)
is a key element for complete response in the treatment of breast
cancer with a five-year survival in the range of 93 to 99%.1
Breast density is a recognized strong and independent risk
factor for breast cancer: high breast density involves a four to
six times higher risk as compared to low density.2,3 Several U.S.
states have already recognized the importance of knowing
whether a subject has high breast density, enacting laws that
require mammography providers to add such notification in
the summary of mammography report. Including breast density
into risk prediction models has improved their prediction accu-
racy. The U.S. Preventive Services Task Force has also sug-
gested the possibility of chemoprevention for women at high
risk.4 Thus, improved risk models could be used to better
address not only closer screening of high-risk women but also
prevention of breast cancer.
At present, breast density is assessed based on the radiologi-
cal appearance of breast tissue (mammographic density). Thus
it is known only at the first mammogram, typically at the age of
40 to 50, depending on the country.5 A tool for its noninvasive
estimation would allow the early identification of high-risk
women, enabling the design of personalized screening and
diagnostic paths. Due to the high incidence of breast cancer
and effectiveness of interventions performed at an early stage,
any significant improvement in the diagnostic procedure (espe-
cially an earlier diagnosis) would have a strong impact on both
the number of spared lives and the quality of life.
Optical techniques can provide functional and structural
information on biological tissue in an absolutely noninvasive
way, and they have already been successfully applied to the
characterization of breast tissue.6–9 Also, extensive clinical trials
showed that raw data on optical attenuation interpreted using
principal component analysis strongly correlate with quantita-
tive mammographic features.10
We have further exploited the potential of diffuse optical
spectroscopy operating in the time domain to assess both tissue
composition in terms of key constituents (water, lipids, collagen,
and hemoglobin) and scattering parameters that are related to the
overall structure of tissue at microscopic level and specifically to
breast density.11,12 Besides the noninvasive assessment of breast
density,13,14 these pieces of information can contribute to a better
understanding of the role of mammographic density in breast
cancer risk and may even provide a more specific link than
x-ray measures with breast cancer risk.
In this work, we propose the use of time-resolved transmit-
tance spectroscopy to identify noninvasively high breast density
subjects who are at high risk for developing breast cancer.
Our portable clinical instrument for time-resolved optical
mammography operates in transmittance geometry on the
mildly compressed breast. Time-resolved transmittance data are
collected at seven red and near-infrared wavelengths (i.e., 635,
680, 785, 905, 930, 975, and 1060 nm), using picosecond pulsed
diode lasers as light sources, and two photomultiplier tubes and
personal computer boards for time-correlated single photon
counting to detect the time distributions of the transmitted
pulses. Injection and collection fibers are scanned in tandem
over the compressed breast and data are stored every millimeter.
Images are routinely acquired from both breasts in cranio-caudal
and oblique (45 deg) views. Time-resolved spectral data are
interpreted with the solution of the diffusion equation for an
infinite homogeneous slab, using a spectrally constrained global
fitting procedure to estimate tissue composition in terms of oxy-
and deoxyhemoglobin, water, lipid, and collagen content, as well
as scattering parameters (amplitude a and power b).15 Moreover,
for the detection of breast lesions, scattering maps are routinely
applied, together with late gated intensity images that are sensitive
to spatial changes in the absorption properties. Details on the
instrument setup and performances, and on the procedures for
data acquisition and analysis, are reported in Ref. 16.
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The instrument is presently applied in a clinical study
approved by the institutional review board of the European
Institute of Oncology. The study has a twofold aim: the optical
characterization of malignant and benign breast lesions and the
noninvasive assessment of breast density. The present work
focuses on the latter aim. Thus, for each subject, all data from
the four images (cranio-caudal and oblique views of both
breasts) were averaged to provide the average optical properties
and breast tissue composition of that subject. Data were col-
lected from 179 patients, recruited between June 2009 and June
2012. Written informed consent was obtained from all of them.
For 32 subjects, recent x-ray mammograms were not available;
thus they were excluded from further analysis. General patient
information for the remaining 147 subjects is as follows: age
52.2 11.3 years, body mass index 23.4 3.7 kg∕m2, 69 sub-
jects in premenopausal status. An expert radiologist assigned
Breast Imaging and Reporting Data System (BI-RADS)
mammographic density categories as (1) almost entirely fat
(category 1, n ¼ 19); (2) scattered fibroglandular densities
(category 2, n ¼ 37); (3) heterogeneously dense (category 3,
n ¼ 56); and (4) extremely dense (category 4, n ¼ 35).
The dependence of tissue composition and scattering param-
eters on mammographic density, classified through BI-RADS
categories, was investigated. The results essentially confirm
what we have observed previously on a more limited number
of subjects.13 Based on the Wilcoxon test, there is no statistically
significant difference between BI-RADS categories 1 and 2 for
any parameters but water, while the difference is highly signifi-
cant for all parameters but oxygenation level (SO2) in the case of
BI-RADS 2 versus 3, and for all parameters but SO2 and total
hemoglobin content (tHb) in the case of BI-RADS 3 versus 4.
Specifically, increasing breast density corresponds to progres-
sively increasing average amounts of water and collagen, while
the lipid content decreases gradually. An increase in BI-RADS
categories is also observed in both scattering amplitude a and
slope b, in agreement with differences in microscopic structures
expected for fatty and fibroglandular tissue. The blood param-
eters (i.e., tHb and SO2) are less sensitive, with only tHb show-
ing a slight increase with mammographic density.
We have also investigated the cross-dependence between
optically derived tissue parameters. The results obtained on
the linear correlation are summarized in Table 1. The strongest
(negative) correlation is observed between lipid and water con-
tent, but negative correlation is also evident between lipid and
collagen content. Both observations are in agreement with what
was expected based on breast tissue composition: moving from
adipose to fibroglandular breasts, the amount of adipose tissue
with high lipid content decreases and is replaced by connective
and epithelial tissue, richer in water and collagen. Marked cor-
relation also exists between the scattering amplitude a and the
concentrations of all major tissue constituents. Specifically, the
correlation is positive for water and collagen, while it is negative
for lipid, consistent with the hypothesis that fibroglandular tis-
sue, rich in water and collagen, is mainly responsible for breast
tissue scattering.
To develop a procedure for the identification of high-risk
women, the mammographic density was dichotomized, compar-
ing subjects in BI-RADS categories 1 to 3 to subjects in cat-
egory 4, the latter being at significantly higher risk than all
the others.2 The p values of the Wilcoxon test showed that
tHb, lipid, water, collagen, a, and b are significantly different
in the two populations considered (at least p < 0.001), while
SO2 is not. The best regression logistic model for the risk prob-
ability chosen via a stepwise variables selection minimizing the
Akaike information criterion resulted to be
logitðpiÞ ¼ α0 þ α1½Collageni þ α2αi þ α3bi; (1)
where pi is the probability of belonging to BI-RADS category 4
(high risk) for the i’th subject. Table 2 shows the output of the
fitted regression logistic model (point estimates of the coeffi-
cients, related standard errors, z-statistics, and p values of test-
ing their significance in the model). The Brier’s score, i.e., the
mean square difference between outcome and estimated proba-
bility, is equal to 0.095.
Table 1 Correlation estimates (95% confidence intervals of Pearson association) of the optically derived parameters.
a b tHb SO2 Lipid Water Collagen
a /
b 0.23 (0.07,0.38) /
tHb 0.41 (0.27,0.54) 0.17 (0.01,0.32) /
SO2 0.09 (−0.07, 0.25) −0.36 (−0.50, −0.21) 0.28 (0.13,0.43) /
Lipid −0.77
(−0.83;−0.69)
−0.49 (−0.61, −0.36) −0.55
(−0.66, −0.43)
−0.13 (−0.03, 0.04) /
Water 0.79 (0.72, 0.84) 0.42 (0.28, 0.55) 0.45 (0.32, 0.57) 0.07 (0.09, 0.23) −0.90 (−0.92, −0.86) /
Collagen 0.69 (0.59, 0.76) 0.11 (−0.05, 0.27) 0.58 (0.46, 0.66) 0.33 (0.17, 0.46) −0.78 (−0.84, −0.71) 0.70
(0.61, 0.78)
/
Table 2 Output of the fitted regression logistic model.
Coefficients Estimate Standard error z value p value
α0 (intercept) −10.460869 1.968482 −5.314 1.07 × 10−7
α1 (collagen) 0.015704 0.006862 2.289 0.0221
α2 (a) 0.227804 0.114084 1.997 0.0458
α3 (b) 6.287575 1.218039 5.162 2.44 × 10−7
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Based on Eq. (1) and Table 2, the probability of belonging to
the high-risk category depends on collagen concentration and on
both scattering parameters. In particular, the strongest depend-
ence occurs for the scattering slope b. Performing in vivo mea-
surements, we have recently observed that high scattering slope
corresponds to high collagen content and possibly depends also
on its structure.17 Collagen content also shows a significant
correlation with the scattering amplitude a, as highlighted in
Table 1. Thus, both directly and indirectly, collagen seems to
be the most crucial feature for the identification of subjects
with high breast density.
The receiver operating characteristic curve for our model is
reported in Fig. 1. We classify the subject as a high-risk patient if
the estimated probability [Eq. (1)] is greater than 0.5. The cor-
responding misclassification matrix is reported in Table 3, where
“true” refers to risk classification based on mammographic
assessment (BI-RADS categories) and “classified” refers to
risk as predicted based on logistic regression fitted on optical
data. The data reported in Table 3 correspond to a total misclas-
sification error of 12.3%, sensitivity of 69%, and specificity of
94%. A simple kappa of 0.84 is achieved, to be compared with
the reproducibility of BI-RADS assignment among radiologists
and even intraradiologists. Specifically, an intrarater agreement
of 77% is reported in the literature, leading to a simple kappa
of 0.58.18 Thus, the classification achieved by optical means
appears to be very promising.
In summary, a logistic regression model was fitted to opti-
cally derived tissue parameters with the aim of identifying
women at high risk for developing breast cancer because of
their high breast density. Encouraging preliminary results were
obtained, and collagen proved to be the key parameter for the
classification, either directly (collagen content) or indirectly
(through scattering amplitude and slope). The relevance of col-
lagen is in agreement with what was expected based on breast
anatomy and physiology, and opens up the possibility of a more
direct estimate of breast density than presently achieved using
x-ray mammography, which is mostly sensitive to water content
and not directly to collagen.
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Fig. 1 Receiver operating characteristic curve for the prediction of high
risk using Eq. (1).
Table 3 Misclassification matrix.
Classified (optical)
Low risk High risk
True (BI-RADS) Low risk 105 7
High risk 11 24
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